Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Arrowhead Pharmaceuticals to Participate in Upcoming March 2020 Conferences

Abstract:
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

Arrowhead Pharmaceuticals to Participate in Upcoming March 2020 Conferences

Pasadena. CA | Posted on March 3rd, 2020

Barclays Global Healthcare Conference– Miami, March 10-12, 2020

March 11, 11:15 a.m. ET – Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will participate in a hybrid podium/fireside chat presentation

5th Annual Oligonucleotide & Precision Therapeutics Congress– Cambridge, MA, March 16-19, 2020

March 17, 2:00 p.m. ET – Mark Yen, M.D., Arrowhead’s director of clinical development, will deliver an oral presentation titled, “Arrowhead TRiM Platform in the Clinic”

Oppenheimer 30th Annual Healthcare Conference – New York, March 17-18, 2020

March 18, 3:55 p.m. ET – Bruce Given will participate in a fireside chat presentation

A copy of the presentation materials and webcast links, if the presentation is being webcast, may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.

####

About Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing.

For more information, please visit www.arrowheadpharma.com, or follow us on Twitter @ArrowheadPharma. To be added to the Company's email list and receive news directly, please visit http://ir.arrowheadpharma.com/email-alerts .

Safe Harbor Statement under the Private Securities Litigation Reform Act:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the safety and efficacy of our product candidates, the duration and impact of regulatory delays in our clinical programs, our ability to finance our operations, the likelihood and timing of the receipt of future milestone and licensing fees, the future success of our scientific studies, our ability to successfully develop and commercialize drug candidates, the timing for starting and completing clinical trials, rapid technological change in our markets, and the enforcement of our intellectual property rights. Our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q discuss some of the important risk factors that may affect our business, results of operations and financial condition. We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances.

For more information, please click here

Contacts:
Arrowhead Pharmaceuticals, Inc.
Vince Anzalone, CFA
626-304-3400


Investors and Media:
LifeSci Advisors, LLC
Brian Ritchie
212-915-2578

www.lifesciadvisors.com

Copyright © Arrowhead Pharmaceuticals, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A step ahead in the race toward ultrafast imaging of single particles April 9th, 2020

House cleaning on the nanoscale: FAU scientists develop method for cleaning surfaces at the nanoscale April 8th, 2020

A twist connecting magnetism and electronic-band topology: Combined optical and torque measurements establish the microscopic mechanism linking magnetism and electronic-band topology in a Dirac material April 7th, 2020

New measurements reveal evidence of elusive particles in a newly-discovered superconductor: Material may be natural home to quasiparticle hiding for decades April 3rd, 2020

Possible Futures

A step ahead in the race toward ultrafast imaging of single particles April 9th, 2020

House cleaning on the nanoscale: FAU scientists develop method for cleaning surfaces at the nanoscale April 8th, 2020

A twist connecting magnetism and electronic-band topology: Combined optical and torque measurements establish the microscopic mechanism linking magnetism and electronic-band topology in a Dirac material April 7th, 2020

New measurements reveal evidence of elusive particles in a newly-discovered superconductor: Material may be natural home to quasiparticle hiding for decades April 3rd, 2020

Investments/IPO's/Splits

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 17th, 2020

180 Degree Capital Corp. Reports 15.9% Annual Increase and 0.3% Quarter Increase in Net Asset Value Per Share to $3.06 as of December 31, 2019 February 24th, 2020

180 Degree Capital Corp. to Report Fourth Quarter 2019 Financial Results on Monday, February 24, 2020 and to Host a Conference Call on Tuesday, February 25, 2020 February 20th, 2020

180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020

Nanomedicine

3D reconstructions of individual nanoparticles: Liquid phase electron microscopy illuminates 3D atomic structures of platinum nanoparticles, advancing full control of nanoengineering April 3rd, 2020

O-FIB: Far-field-induced near-field breakdown for direct nanowriting in an atmospheric environment March 20th, 2020

Tokai scientists create the world's first electronic skin-based sensor for heatstroke detection March 17th, 2020

March 17th, 2020

Announcements

A step ahead in the race toward ultrafast imaging of single particles April 9th, 2020

House cleaning on the nanoscale: FAU scientists develop method for cleaning surfaces at the nanoscale April 8th, 2020

A twist connecting magnetism and electronic-band topology: Combined optical and torque measurements establish the microscopic mechanism linking magnetism and electronic-band topology in a Dirac material April 7th, 2020

New measurements reveal evidence of elusive particles in a newly-discovered superconductor: Material may be natural home to quasiparticle hiding for decades April 3rd, 2020

Events/Classes

The National Space Society not holding the International Space Development Conference 2020 in May Due to COVID-19 Concerns March 19th, 2020

Global Summit on Material Science and Nanotechnology March 5th, 2020

National Space Society to Honor NASA's Juno Mission Team at Its 2020 International Space Development Conference: Dr. Scott Bolton, Juno Mission Principal Investigator, to Accept February 28th, 2020

CEA-Leti and CEA-IRIG Demonstrate Quantum Integrated Circuit Combining Quantum Dot with Digital-Analog Circuits on CMOS Chip: Presentation at ISSCC 2020 Shows Role FD-SOI Can Play in Embedding Qubit Arrays with Classic Electronics to Build Large-Scale Quantum Silicon Processors February 20th, 2020

Nanobiotechnology

3D reconstructions of individual nanoparticles: Liquid phase electron microscopy illuminates 3D atomic structures of platinum nanoparticles, advancing full control of nanoengineering April 3rd, 2020

March 17th, 2020

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 17th, 2020

Curcumin is the spice of life when delivered via tiny nanoparticles: Treatment for Alzheimer's and genital herpes March 6th, 2020

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project